Literature DB >> 27016366

Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.

Francesc Miralles1.   

Abstract

Myasthenia gravis (MG) is an autoimmune postsynaptic disorder of neuromuscular transmission caused, in most patients, by antibodies against postsynaptic acetylcholine receptors. Lambert-Eaton myasthenic syndrome (LEMS) is a presynaptic autoimmune disease in which there is a reduction in Ca2+ entry with each impulse due to the action of antibodies against Ca2+ channels. These diseases have a distinct pattern of response to low-frequency repetitive nerve stimulation which allows its recognition in a particular subject. Nevertheless, the physiologic basis of this response is not entirely known. A model of the time-course of release probability of neuromuscular junctions that incorporates facilitation and a depression-recovery mechanism has been developed with the aim to investigate these response patterns. When the basal value of release probability was in the physiologic range, as in MG, release probability showed an increment after its initial decrease only if the recovery from depression was accelerated by presynaptic residual Ca2+. Otherwise, when the basal release probability was low, as in LEMS, a progressive reduction in the release probability without any late increase was only obtained if the efficacy of Facilitation and Ca2+-dependent recovery from depression were reduced.

Entities:  

Keywords:  Computer simulation; Electromyography; Lambert–Eaton myasthenic syndrome; Myasthenia gravis; Synaptic transmission

Mesh:

Substances:

Year:  2016        PMID: 27016366     DOI: 10.1007/s11517-016-1462-4

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  44 in total

1.  Change of statistical parameters of transmitter release during various kinetic tests in unparalysed voltage-clamped rat diaphragm.

Authors:  M I Glavinović
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

2.  Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.

Authors:  Shin J Oh; Katsumi Kurokawa; Gwen C Claussen; Hewitt F Ryan
Journal:  Muscle Nerve       Date:  2005-10       Impact factor: 3.217

3.  Electromyographic aspects of neuromuscular junction disorders.

Authors:  C Michel Harper
Journal:  Handb Clin Neurol       Date:  2008

4.  Low rate repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome: peculiar characteristics of decremental pattern from a single-centre experience.

Authors:  Marco Luigetti; Anna Modoni; Mauro Lo Monaco
Journal:  Clin Neurophysiol       Date:  2012-10-01       Impact factor: 3.708

Review 5.  Calcium channels and short-term synaptic plasticity.

Authors:  William A Catterall; Karina Leal; Evanthia Nanou
Journal:  J Biol Chem       Date:  2013-02-11       Impact factor: 5.157

Review 6.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

7.  Kinetic and pharmacological examination of stimulation-induced increases in synaptic efficacy in the chick ciliary ganglion.

Authors:  R E Poage; J E Zengel
Journal:  Synapse       Date:  1993-05       Impact factor: 2.562

8.  Depression, facilitation, and mobilization of transmitter at the rat diaphragm neuromuscular junction.

Authors:  D F Wilson
Journal:  Am J Physiol       Date:  1979-07

9.  Effects of calcium channel blockers on stimulation-induced changes in transmitter release at the frog neuromuscular junction.

Authors:  J E Zengel; D T Lee; M A Sosa; D R Mosier
Journal:  Synapse       Date:  1993-12       Impact factor: 2.562

10.  A quantitative description of stimulation-induced changes in transmitter release at the frog neuromuscular junction.

Authors:  K L Magleby; J E Zengel
Journal:  J Gen Physiol       Date:  1982-10       Impact factor: 4.086

View more
  1 in total

Review 1.  Lambert-Eaton Myasthenic syndrome: early diagnosis is key.

Authors:  Trajche Ivanovski; Francesc Miralles
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.